PLUTAVIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 17:40:57 GMT 2023` Edited by `admin` on `Sat Dec 16 17:40:57 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	12U14K0SR5
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PLUTAVIMAB

Official Name

English

COVI-AMG

Brand Name

English

IMMUNOGLOBULIN G1 (234-ALANINE,235-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL STI-2020 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL STI-2020 .KAPPA.-CHAIN, DIMER

Common Name

English

STI2020

Code

English

STI-2020

Code

English

STI-2099

Code

English

AFFINITY MATURED COVI-GUARD

Common Name

English

plutavimab [INN]

Common Name

English

PLUTAVIMAB [USAN]

Common Name

English

STI2099

Code

English

COVI-DROPS

Brand Name

English

STI 2020 [WHO-DD]

Common Name

English

Code System Code Type Description

SMS_ID

300000039967

Created by admin on Sat Dec 16 17:40:58 GMT 2023 , Edited by admin on Sat Dec 16 17:40:58 GMT 2023

PRIMARY

NCI_THESAURUS

C182098

Created by admin on Sat Dec 16 17:40:58 GMT 2023 , Edited by admin on Sat Dec 16 17:40:58 GMT 2023

PRIMARY

FDA UNII

12U14K0SR5

Created by admin on Sat Dec 16 17:40:58 GMT 2023 , Edited by admin on Sat Dec 16 17:40:58 GMT 2023

PRIMARY

USAN

JK-186

Created by admin on Sat Dec 16 17:40:58 GMT 2023 , Edited by admin on Sat Dec 16 17:40:58 GMT 2023

PRIMARY

INN

12159

Created by admin on Sat Dec 16 17:40:58 GMT 2023 , Edited by admin on Sat Dec 16 17:40:58 GMT 2023

PRIMARY

CAS

2529854-88-2

Created by admin on Sat Dec 16 17:40:58 GMT 2023 , Edited by admin on Sat Dec 16 17:40:58 GMT 2023

PRIMARY

From	To
1_22	1_95
2_22	2_95
2_144	2_200
2_220	4_214
2_261	2_321
1_144	1_200
2_367	2_425
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194
1_220	3_214
1_226	2_226
1_229	2_229
1_261	1_321
1_367	1_425

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_297
N	2_297

Related Record Type Details


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->INHIBITOR

Interaction Type:

IN-VITRO

Amount:

Related Record Type Details


					12U14K0SR5

ACTIVE MOIETY

Interaction Type:

IN-VITRO

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL